Substituted 2,4 diamino-quinoline as new anticancer agents
US10722505B2 · kind B2 · utility
0Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2015 |
| Grant date | Jul 28, 2020 |
| Priority date | — |
| Expiry date | Dec 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicaments. The active compounds of the present invention are useful for the treatment and prevention of proliferative neoplastic and non-neoplastic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.